Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis
Da‐Long He(China Medical University), Zhan‐You Wang(China Medical University)
Cited by 13
Related Papers
Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model
|Molecular Neurodegeneration|2010|156
Prostaglandin I2 Attenuates Prostaglandin E2-Stimulated Expression of Interferon γ in a β-Amyloid Protein- and NF-κB-Dependent Mechanism
|Scientific Reports|2016|19
Astrocyte-derived lactoferrin reduces Aβ burden by promoting the interaction of p38 and PP2A in APP/PS1 transgenic mice
|Unknown|2022|1
<scp>AS1842856</scp> Reduces β‐Amyloid Burden via Inhibiting <scp>PLA2G4A</scp> ‐Mediated Lysosomal Dysfunction in <scp>APP</scp> / <scp>PS1</scp> Mice
|CNS Neuroscience & Therapeutics|2026|0